Medicare Enrolled
Dr. Dustin Thrash, MD
Internal Medicine · Dallas, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Thrash from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Thrash?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Thrash
Dr. Dustin Thrash is an internal medicine specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Thrash performed 6,569 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Thrash received a total of $21,839 from 54 pharmaceutical and/or device companies across 1151 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Thrash is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 5% volume in TX
$21,839 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,569
Medicare services
Top 5% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,524 | $5 | $23 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,016 | $64 | $297 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
643 | $30 | $223 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
444 | $87 | $378 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
429 | $65 | $338 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
266 | $301 | $1,275 |
| Light therapy to destroy precancerous skin growth This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous. |
239 | $100 | $466 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
209 | $41 | $168 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
146 | $235 | $1,011 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
114 | $74 | $369 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
68 | $103 | $813 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 63 | $253 | $1,052 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
61 | $122 | $562 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
54 | $109 | $889 |
| Destruction of skin growth, 15 or more growths | 40 | $91 | $441 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
33 | $103 | $839 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
32 | $104 | $927 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
25 | $233 | $1,031 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
24 | $51 | $321 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $99 | $420 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
19 | $193 | $878 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
17 | $70 | $572 |
| Skin cancer removal, face/ears/eyes/nose/lips, 2.1-3.0 cm Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 2.1 and 3.0 centimeters. |
15 | $120 | $1,045 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
14 | $45 | $190 |
| Intermediate wound repair, face or mouth, 2.5 cm or less A medical procedure to close a wound on the face, ears, eyelids, nose, lips, or mouth that is 2.5 centimeters or smaller. This type of repair involves more than simple closure but is less complex than a major repair. |
14 | $216 | $946 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
13 | $64 | $521 |
| Surgical removal of skin cancer, 2.1-3.0 cm Surgical excision of a cancerous skin growth measuring 2.1 to 3.0 centimeters from the scalp, neck, hands, feet, or genitals. |
13 | $111 | $983 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
11 | $1 | $24 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$21,839
Total received (2018-2024)
Avg $3,120/year across 7 years
Top 4% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
1,151
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,254
2023
$3,328
2022
$3,855
2021
$3,760
2020
$2,047
2019
$2,356
2018
$3,239
Payments by company (2024)
ABBVIE INC.
$533
SUN PHARMACEUTICAL INDUSTRIES INC.
$380
GENZYME CORPORATION
$347
Arcutis Biotherapeutics, Inc.
$325
Dermavant Sciences, Inc.
$323
Lilly USA, LLC
$280
Novartis Pharmaceuticals Corporation
$225
UCB, Inc.
$120
Regeneron Healthcare Solutions, Inc.
$99
PFIZER INC.
$85
Journey Medical Corporation
$78
REVANCE THERAPEUTICS, INC.
$76
Incyte Corporation
$76
Janssen Biotech, Inc.
$72
E.R. Squibb & Sons, L.L.C.
$35
Amgen Inc.
$35
Galderma Laboratories, L.P.
$33
MAYNE PHARMA COMMERCIAL LLC
$29
Fidia Pharma USA Inc.
$26
LEO Pharma Inc.
$17
Kyowa Kirin, Inc.
$16
Paratek Pharmaceuticals, Inc.
$15
Ortho Dermatologics, a division of Bausch Health US, LLC
$15
Verrica Pharmaceuticals Inc.
$13
Top 3 companies account for 38.7% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$2,232
Lilly USA, LLC
$1,783
ABBVIE INC.
$1,626
Novartis Pharmaceuticals Corporation
$1,180
Sun Pharmaceutical Industries Inc.
$1,117
AbbVie, Inc.
$1,087
GENZYME CORPORATION
$1,082
Medimetriks Pharmaceuticals, Inc.
$883
Regeneron Healthcare Solutions, Inc.
$870
SUN PHARMACEUTICAL INDUSTRIES INC.
$858
Encore Dermatology Inc.
$721
Dermavant Sciences, Inc.
$708
PFIZER INC.
$693
Journey Medical Corporation
$603
Arcutis Biotherapeutics, Inc.
$593
Janssen Biotech, Inc.
$549
LEO Pharma Inc.
$503
Galderma Laboratories, L.P.
$482
Ortho Dermatologics, a division of Bausch Health US, LLC
$436
MAYNE PHARMA INC.
$413
Incyte Corporation
$409
Almirall LLC
$390
UCB, Inc.
$265
Mayne Pharma Inc.
$246
Amgen Inc.
$243
EPI Health, LLC
$192
VYNE Pharmaceuticals Inc.
$185
Exeltis, USA Inc.
$164
DUSA Pharmaceuticals, Inc.
$148
Allergan, Inc.
$142
E.R. Squibb & Sons, L.L.C.
$139
Glenmark Therapeutics Inc.
$103
Biofrontera Inc.
$84
MAYNE PHARMA COMMERCIAL LLC
$81
REVANCE THERAPEUTICS, INC.
$76
DERMIRA, INC.
$60
Sebela Pharmaceuticals Inc.
$55
Aclaris Therapeutics, Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Sandoz Inc.
$40
Mylan Pharmaceuticals Inc.
$38
Helsinn Therapeutics (U.S.), Inc.
$36
Tactile Systems Technology Inc
$33
Allergan Inc.
$27
Fidia Pharma USA Inc.
$26
Taro Pharmaceuticals USA, Inc.
$24
Novum Pharma, LLC
$20
Mission Pharmacal Company
$18
Blueprint Medicines Corporation
$18
Kyowa Kirin, Inc.
$16
Paratek Pharmaceuticals, Inc.
$15
Verrica Pharmaceuticals Inc.
$13
Celgene Corporation
$12
PruGen, Inc. Pharmaceuticals
$8
Top 3 companies account for 25.8% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Aczone · Alcortin A · Avar · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CLODERM · COSENTYX · Cabtreo · Ceracade · Cimzia · Clindacin ETZ · Clindamycin Phosphate and Benzoyl Peroxide · Cordran Tape · DAXXIFY · DORYX · DUOBRII · DUPIXENT · EBGLYSS · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · Enbrel · Exelderm · Flexitouch Plus · Genadur · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · JUBLIA EFINACONAZOLE · KERYDIN · Klisyri · LEVULAN KERASTICK · LIBTAYO · LUZU LULICONAZOLE · Mupirocin Cream · NAFTIN · NUZYRA · Neo-Synalar · Neo-Synalar Cream · Neo-Synalar Cream Kit · Neocera · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Olux · Otezla · PRAMOSONE · Poteligeo · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOLODYN · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Skyrizi · Sotyktu · Sumadan Kit · TALTZ · TREMFYA · TargaDox · Tremfya · ULTRAVATE · USP) 0.1% · VALCHLOR · VTAMA · Veltin · Winlevi · XOLAIR · YCANTH · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
2,180
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Thrash is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Thrash experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Thrash performed 2,524 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Thrash receive payments from pharmaceutical companies?
Yes. Dr. Thrash received a total of $21,839 from 54 companies across 1,151 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Thrash's costs compare to other internal medicine physicians in Dallas?
Dr. Thrash's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Thrash) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Dallas
Browse internal medicine physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology